Reversing Time: The First Human Clinical Trial for Cellular Rejuvenation Therapy

Explore the frontier of longevity science as we examine Life Biosciences' groundbreaking human clinical trial for ER-100. This therapy, rooted in epigenetic reprogramming, aims to reverse cellular aging to treat vision loss. We analyze the scientific promise of restoring retinal ganglion cells, the strategic choice of targeting eye conditions, and the cautious perspectives from experts regarding safety and the hype surrounding anti-aging technology. Join us as we discuss whether this trial marks the beginning of a new era in medicine or if the risks of cellular manipulation remain too high for human application.📥 Connect with The Well-Built LifeIf you enjoyed today’s conversation, please take a moment to follow or subscribe to the channel on your favorite platform so you never miss a practical health and wellness tip.Spreaker: Spreaker Podcast LinkBusiness Inquiries: Contact Us☕ Support the ShowThis podcast is completely independent and ad-free, relying entirely on listeners like you to keep it going. If you find value in our episodes and are in a position to do so, please consider supporting our work. You can buy us a coffee or make a small donation through the link below - every single bit helps us keep creating practical, easy-to-understand health content.Support & Buy Us A Coffee Here: PayPal🌱 About The Well-Built LifeWe cut through the complicated fitness fads and confusing trends to bring you simple, actionable tips for everyday health, nutrition, and mindset. No extreme rules or heavy jargon - just realistic strategies to help you live a stronger, more balanced life.This episode includes AI-generated content.